POLYMORPHISM OF THE GENE ENCODING ADIPONEKTIN (+276 G> T ADIPOQ), AND EXPRESSION OF INSULIN-RESISTANT CONDITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (literature review and own data)
DOI:
https://doi.org/10.21856/j-PEP.2011.2.11Keywords:
AdiponectinAbstract
Adiponectin, also known as ACRP30, GBP28 and AdipoQ, is a hormone that is exclusively secreted by adipocytes. For the last several years, he has been paying particular attention to the potential role in the genesis of diabetes. The anti-inflammatory, insulin-sensitizing properties of this hormone, its ability to modulate glucose homeostasis and the metabolism of high-density lipoproteins have been proven.
References
A novel serum protein similar to C1q, produced exclusively in adipocytes [Text] / P. E. Scherer, S. Williams, M. Fogliano [et al.] // J. Biol. Chem. — Vol. 270 (45). — P. 26746–91995.
Hu E. AdipoQ is a novel adipose-specific gene dysregulated in obesity [Text] / E. Hu, P. Liang, B. M. Spiegelman // J. Biol. Chem. — 1996. — Vol. 271 (18). — P. 10697–10703.
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1) [Text] / K. Maeda, K. Okubo, I. Shimomura [et al.] // Biochem. Biophys. Res. Commun. — 1996. — Vol. 16; 221 (2). — P. 286–289.
Adiponectin does not bind to gelatin: a new and easy way to purify high-molecular-weight adiponectin from human plasma [Text] / Y. Nakano, A. Shoji, A. Arakawa [et al.] // J. Lipid Res. — 2010. — Vol. 51 (1). — P. 210–215.
Scherer P. E. Adipose tissue: from lipid storage compartment to endocrine organ [Text] / P. E. Scherer // Diabetes. — 2006. — Vol. 55 (6). — P. 1537–1545.
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity [Text] / Y. Arita, S. Kihara, N. Ouchi [et al.] // Biochem. Biophys. Res. Commun. — 1999. — Vol. 257 (1). — P. 79–83.
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients [Text] / K. Hotta, T. Funahashi, Y. Arita [et al.] // Arterioscler Thromb. Vasc. Biol. — 2000. — Vol. 20 (6). — P. 1595–1599.
Association of hypoadiponectinemia with coronary artery disease in men [Text] / M. Kumada, S. Kihara, S. Sumitsuji [et al.] // Osaka CAD Study Group. Coronary artery disease. Arterioscler. Thromb. Vasc. Biol. — 2003. — Vol. 23 (1). — P. 85–89.
Heilbronn L. K. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity [Text] / L. K. Heilbronn, L. V. Campbell // Curr. Pharm. Des. — 2008. — Vol. 14 (12). — P. 1225–1230.
Plasma adiponectin and endogenous glucose production in humans [Text] / N. Stefan, M. Stumvoll, B. Vozarova [et al.] // Diabetes Care. — 2003. — Vol. – 26 (12). — P. 3315–3319.
Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism [Text] / O. Tschritter, A. Fritsche, C. Thamer [et al.] // Diabetes. — 2003. — Vol. 52 (2). — P. 239–243.
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers [Text] / D. Rothenbacher, H. Brenner, W. M¨arz, W. Koenig // Europ. Heart. J. — 2005. — Vol. 26 (16). — P. 1640–1646.
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia [Text] / C. Weyer, T. Funahashi,S. Tanaka [et al.] // J. Clin. Endocrinol. Metabol. — 2001. — Vol. 86 (5). — P. 1930–1935.
Adiponectin and development of type 2 diabetes in the Pima Indian population [Text] / R. S. Lindsay, T. Funahashi, R. L. Hanson [et al.] // Krakoff J. Lancet. — 2002. — Vol. 6. — P. 57–58.
Spranger J. New concepts in pathogenesis and treatment of diabetic retinopathy [Text] / J. Spranger, A. F. Pfeiffer // Exp Clin Endocrinol. Diabetes. — 2001. — Vol. 109. — Suppl 2. — S438–50.
Association of hypoadiponectinemia with coronary artery disease in men [Text] / M. Kumada, S. Kihara, S. Sumitsuji [et al.] // Osaka CAD Study Group. Coronary artery disease. Arterioscler. Thromb. Vasc. Biol. — 2003. — Vol. 23 (1). — P. 85–89.
Plasma adiponectin levels and risk of myocardial infarction in men [Text] / T. Pischon, C. J. Girman, G. S. Hotamisligil [et al.] // JAMA. — 2004. — Vol. 291 (14). — P. 1730–1737.
Рiвнi адипонектину у хворих на цукровий дiабет 2 типу за зiставленням з класичними та новiтнiми чинниками атерогенезу [Текст] / М. Ю. Горшунська, Ю. I. Караченцев, Н. С. Красова [та iн.] // Ендокринологiя. — 2007. — Т. 12, № 2. — С. 252–260.
Уровень адипонектина у пациентов с абдоминальным ожирением —носителей различных генотипов гена адипонектина [Текст] / О. Д. Беляева, Е. А. Баженова, А. В. Березина [и др.] // Вестник Санкт-Петербургского университета. — 2009. — Вып. 4. — С. 36–48.
Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells [Text] / N. Ouchi, H. Kobayashi, S. Kihara [et al.] // J. Biol. Chem. — 2004. — Vol. 279 (2). — P. 1304–1309.
Hulthe J. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense lowdensity lipoprotein particles: atherosclerosis and insulin resistance study [Text] / J. Hulthe, L. M. Hult´en, B. Fagerberg //Metabolism. — 2003. — Vol. 52 (12). — P. 1612–1614.
Adiponectin as a biomarker of the metabolic syndrome [Text] / M. Ryo, T. Nakamura, S. Kihara [et al.] // Circ. J. — 2004. — Vol. 68 (11). — P. 975–981.
Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men [Text] / T. Yatagai, Y. Nishida, S. Nagasaka [et al.] // Endocrinol. J. — 2003. — Vol. 50 (2). — P. 233–238.
Shulze M. B. Primary prevention of diabetes: what can be done and how much can be prevented? [Text] / M. B. Shulze, F. B. Hu // Ann. Rev. Public. Heath. — 2005. — Vol. 26. — P. 445–467.
Regulation of gelatin-binding protein 28 (GBP28) gene expression by C/EBP [Text] / K. Saito, T. Tobe, M. Yoda [et al.] // Biol. Pharm. Bull. — 1999. — Vol. 22 (11). — P. 1158–1162.
Genomic structure and mutations in adipose-specific gene, adiponectin [Text] / M. Takahashi, Y. Arita, K. Yamagata [et al.] // Int. J. Obes. Relat. Metabol. Disord. — 2000. — Vol. 24 (7). — P. 861–868.
Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome
q21-q24. [Теxt] / N. Vionnet, E. H. Hani, S. Dupont [et al.] // Am. J. Hum. Genet. — 2000. — Vol. 67 (6). — P. 1470–1480.
Genome-wide search for type 2 diabetes in Japanese affected sib-pairs confirms susceptibility genes on 3q, 15q, and 20q and identifies two new candidate Loci on 7p and 11p [Теxt] / Y. Mori, S. Otabe, C. Dina [et al.] // Diabetes. — 2002. — Vol. 51 (4). — P. 1247–1255.
The genes influencing adiponectin levels also influence risk factors for metabolic syndrome and type 2 diabetes [Теxt] / A. G. Comuzzie, M. E. Tejero, T. Funahashi [et al.] // Hum. Biol. — 2007.– Vol. 79 (2). — P. 191–200.
A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome [Теxt] / C. Menzaghi, T. Ercolino, R. D. Paola [et al.] // Diabetes. — 2002. — Vol. 51. — Р. 2306–2312.
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome [Теxt] / A. H. Kissebah, G. E. Sonnenberg, J. Myklebust [et al.] // Proc. Nat. Acad. Sci. USA. — 2000. — Vol. 97. — Р. 4478–14483.
Hara K. Adiponectin: an adipokine linking adipocytes and type 2 diabetes in humans [Text] / K. Hara, T. Yamauchi, T. Kadowaki // Curr. Diab. Rep. — 2005. — Vol. 5 (2). — P. 136–140.
Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome [Теxt] / H. Kondo, I. Shimomura, Y. Matsukawa [et al.] // Diabetes. — 2002. – Vol. 51 (7). — Р. 2325–2328.
Association of the T–G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity [Теxt] / M. Stumvoll, O. Tschritter, A. Fritsche [et al.] // Diabetes. — 2002. – Vol. 51. — Р. 37–41.
Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians
[Теxt] / F. Vasseur, N. Helbecque, C. Dina [et al.] // Hum. Molec. Genet. — 2002. — Vol. 11. — Р. 2607–2614.
Association of the +45T/G and +276G/T polymorphisms in the adiponectin gene with insulin resistance in nondiabetic Greek women [Теxt] / L. Melistas, C. S. Mantzoros, M. Kontogianni [et al.] // Europ. J. Endocrinol. — 2009. — Vol. 161. — P. 845–852.
Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity [Теxt] / T. Kyriakou, L. J. Collins, N. J. Spencer-Jones [et al.] // J. Hum. Genet. – 2008. – Vol. 53 (8). — P. 718–
Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes [Теxt] / L. Qi, A. Doria, J. E. Manson [et al.] // Diabetes. — 2006. — Vol. 55 (5). — P. 1512–1516.
Vimaleswaran K. S. Progress in the genetics of common obesity and type 2 diabetes [Теxt] / K. S. Vimaleswaran, R. J. Loos // Expert. Rev. Mol. Med. — 2010. — Vol. 12. — P. e7.
Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects [Теxt] / D. R. Gable, J. Matin, R. Whittall [et al.] // Ann. Hum. Genet. — 2007. — Vol. 71 (Pt 4). — P. 453–466.
Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians [Text] / I. M. Heid, S. A. Wagner, H. Gohlke [et al.] // Diabetes. — 2006. — Vol. 55,
№ 2. — P. 375–384.
Mohammadzadeh G. Associations between singlenucleotide polymorphisms of the adiponectin gene, serum adiponectin levels and increased risk of type 2 diabetes mellitus in Iranian obese individuals [Теxt] / G. Mohammadzadeh, N. Zarghami //Scand. J. Clin. Lab. Invest. — 2009. –Vol. 69 (7). — P. 764–771.
Menzaghi C. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease [Теxt] / C. Menzaghi, V. Trischitta, A. Doria // Diabetes. — 2007. — Vol. 56, № 5. — P. 1198–1209.
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man [Теxt] / D. R. Matthews, J. P. Hoske, A. S. Rudensk [et al.] // Diabetologia. — 1985. — Vol. 28. — P. 412–419.
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans [Text] / A. Katz, S. S. Nambi, K. Mather [et al.] // J. Clin. Endocrinol. Metabol. — 2000. — Vol. 85. — P. 2402–2410.
Walsh P. S. Chelex 100 as a medium for extraction of DNA for PCR-based typing from forensic material [Text] / P. S. Walsh, D. A. Metzger, R. Higuchi // BioTechniques. — 1991. — № 10. — P. 506–513.
Linkage of plasma adiponectin levels to 3q27 explained by assosiation with variation in the APM1 gene [Text] / T. I. Pollin, K. Tanner, J. R. O’Connell [et al.] // Diabetes. — 2005. — Vol. 54. — Р. 268–274.
Гетерозиготность по SNP +276 G > T гена адипонектина как потенциальный предиктор устойчивости к сахарному диабету 2 типа [Текст] / Ю. И. Караченцев, М. Ю. Горшунская, Л. А. Атраментова [и др.] // Актуальнi проблеми акушерства i гiнекологiї, клiнiчної iмунологiї та медичної генетики. — К.; Луганськ, 2010. — С. 195–199.
Lam Т. К. Т. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites / Т. К. Т. Lam, G. Van de Werue, A. Giacca // Amer. J. Physiol. Endocrinol. Metabol. — 2003. — Vol. 284, № 2. — P. E281–E290.
Variants of the adiponectin gene and type 2 diabetes in a Polish population [Text] / M. Szopa, M. Malczewska-Malec, B. Kiec-Wilk [et al.] // Acta Diabetol. — 2009. — Vol. 46, № 4. — P. 317–322.
Association of the human adiponectin gene and insulin resistance [Text] / E. Filippi, F. Sentinelli, V. Trischitta [et al.] // Europ. J. Hum. Genet. — 2004. — Vol. 12, № 3. — P. 199–205.
The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes [Text] / E. S. Kang, S. Y. Park, H. J. Kim [et al.] // Diabetes Care. — 2005. — Vol. 28, № 5. — P. 1139–1144.
Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity [Text] / W. S. Yang, P. L. Tsou, W. J. Lee [et al.] // J. Molec. Med. — 2003. — Vol. 81, № 7. — P. 428–434.
Single nucleotide polymorphism in prohibitin 39 untranslated region and breast-cancer susceptibility [Text] / E. R. Jupe, A. A. Badgett, B. R. Neas [et al.] // Lancet. — 2001. — Vol. 357. — P. 1588–1589.
A single point mutation at the 3’-UTR of Ran mRNA leads to profound changes in lipopolysaccharide endotoxin-mediated
responses [Text] / P. M. Wong, Q. Yuan, H. Chen [et al.] // J. Biol. Chem. — 2001. — Vol. 276. — P. 33129–33138.
A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes [Text] / J. B. Xia, S. W. Sherer, P. T. Cohen [et al.] // Diabetes. — 1998. — Vol. 47. — P. 1519–1524.
Linkage of Plasma Adiponectin Levels to 3q27 Explained by Association With Variation in the APM1 Gene [Text] / Toni I. Pollin, Keith Tanner, Jeffrey R. O’Connell [et al.] // Diabetes. — 2005. — Vol. 54. — P. 268–274.
Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women [Text] / C. Heidemann, Q. Sun, R. M. van Dam [et al.] // Ann. Intern. Med. — 2008. — Vol. 149 (5). — P. 307–316.